| Practical considerations in medical cannabis administration and dosing |
62 |
| The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report |
37 |
| Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America |
32 |
| Obesity phenotypes and their paradoxical association with cardiovascular diseases |
30 |
| Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review |
29 |
| Human serum albumin in cardiovascular diseases |
24 |
| Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly |
23 |
| Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer |
22 |
| The essence of frailty: A systematic review and qualitative synthesis on frailty concepts and definitions |
17 |
| Gut microbiota and obesity: Concepts relevant to clinical care |
16 |
| Euglycemic diabetic ketoacidosis |
16 |
| Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries |
14 |
| Bringing complexity into clinical practice: An internistic approach |
13 |
| Frailty and atrial fibrillation: A systematic review |
13 |
| Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment |
12 |
| The BIOmarkers associated with Sarcopenia and PHysical frailty in EldeRly pErsons (BIOSPHERE) study: Rationale, design and methods |
12 |
| Patients with isolated pulmonary embolism in comparison to those with deep venous thrombosis. Differences in characteristics and clinical evolution |
11 |
| A new standardized data collection system for interdisciplinary thyroid cancer management: Thyroid COBRA |
11 |
| The therapeutic potential of targeting the peripheral endocannabinoid/CB1 receptor system |
11 |
| New oncologic emergencies: What is there to know about inmunotherapy and its potential side effects? |
10 |
| Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas |
10 |
| Accounting for frailty when treating chronic diseases |
10 |
| The role of gut microbiota in Clostridium difficile infection |
10 |
| Angioedema and emergency medicine: From pathophysiology to diagnosis and treatment |
9 |
| Management of celiac disease in daily clinical practice |
9 |
| Mortality and morbidity for cardiopulmonary diseases attributed to PM2.5 exposure in the metropolis of Rome, Italy |
9 |
| Liver disease and heart failure: Back and forth |
9 |
| Compassionate use of unauthorized drugs: Legal regulations and ethical challenges |
9 |
| Cholecystectomy and risk of metabolic syndrome |
9 |
| JAK inhibitors in synthetic review in 10 points |
8 |
| European and US guidelines for arterial hypertension: similarities and differences |
8 |
| A case-mix classification system for explaining healthcare costs using administrative data in Italy |
8 |
| Primary biliary cholangitis: Old and novel therapy |
7 |
| Cancer immunotherapy-induced endocrinopathies: Clinical behavior and therapeutic approach |
7 |
| Multimorbidity in middle age predicts more subsequent hospital admissions than in older age: A nine-year retrospective cohort study of 188 discharged in-patients |
7 |
| European Journal of Internal Medicine journal homepage: Factors reducing omalizumab response in severe asthma |
7 |
| Appropriateness of statin prescription in the elderly |
7 |
| Biological treatments in giant cell arteritis & Takayasu arteritis |
7 |
| Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study |
7 |
| Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study |
7 |
| Mitigation of air pollution by greenness: A narrative review |
7 |
| Cardiac amyloidosis: An underdiagnosed/underappreciated disease |
7 |
| The role of nutrition in ageing: A narrative review from the perspective of the European joint action on frailty - ADVANTAGE |
7 |
| Frailty predicts short-term survival even in older adults without multimorbidity |
7 |
| Reduction of 24-h blood pressure variability in extreme obese patients 10 days and 6 months after bariatric surgery depending on pre-existing hypertension |
7 |
| Role of age and comorbidities in mortality of patients with infective endocarditis |
7 |
| Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients |
7 |
| Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study |
7 |
| Fifty years of research on antithrombotic therapy: Achievements and disappointments |
6 |
| Secular trends in the association between obesity and hypertension among adults in the United States, 1999-2014 |
6 |
